Brief: Jacobson Pharma Corp Posts H1 Revenue Of HKD 766.6 Million
18/11/2025 10:13
Nov 18 (Reuters) - Jacobson Pharma Corporation Ltd 2633.HK: H1 REVENUE HKD 766.6 MILLION INTERIM DIVIDEND HK4.25 CENTS PER SHARE H1 NET INCOME ATTRIBUTABLE HKD 142 MILLION Further company coverage: 2633.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jacobson Pharma
See all newsBrief: Jacobson Pharma Corp Says Chai Herbal To Buy 124,500 Shares Of Li Chung Shing Tong (Holdings)
Brief: Jacobson Pharma Corp's Unit Accepts Tender For Tai Po Factory Works At Hk$607.2 Million
Brief: Jacobson Pharma Corp Posts H1 Revenue Of HKD 766.6 Million
Brief: Jacobson Pharma Corporation Posts FY Net Income Attributable HKD 300.8 Million
Brief: Jacobson Pharma Corporation To Subscribe Shares In Tycoon Group